Trial Profile
Effect of Alogliptin when given for 52 weeks in patients with diabetes
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 May 2015
Price :
$35
*
At a glance
- Drugs Alogliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 18 May 2015 New trial record